(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays.)By Nancy LapidApril 29 (Reuters) - We also report b
(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays.)By Nancy LapidApril 24 (Reuters) - An outpatient en
(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays.)By Nancy LapidApril 22 (Reuters) - Twice as many ad
(This April 1 Health Rounds has been corrected to change ‘genetic’ to ‘genomic’ in the headline and the first item of the newsletter)By Nancy LapidApril 1 (Reuters) -
By Nancy LapidApril 17 (Reuters) - Researchers have developed a modified version of the CRISPR gene-editing tool that in early laboratory experiments suggests it may have t
(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays.)By Nancy LapidApril 15 (Reuters) - GLP-1 drugs have
By Nancy LapidApril 10 (Reuters) - Weight-loss responses to GLP-1 obesity drugs, and risks of side effects, may be linked to genetic variants, according to a study conducte
(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays)By Nancy LapidApril 8 (Reuters) - An advanced versio
(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays.)By Nancy LapidApril 3 (Reuters) - Doctors should no
(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays.)By Nancy LapidApril 1 (Reuters) - Advanced genetic